TGF-β1 downregulates CD36 and scavenger receptor A but upregulates LOX- 1 in human macrophages

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 4 47-4, 2000, Pages

  Draude, Georg ^a   Lorenz, Reinhard L ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Scavenger receptor class A; Transforming growth factor 1

Indexed keywords

CD36 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; MSR1 PROTEIN, HUMAN; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SCAVENGER RECEPTOR A; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DOWN REGULATION; FOAM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; MACROPHAGE; METABOLISM; MONOCYTE; UPREGULATION;

ANTIGENS, CD36; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION; HUMANS; MACROPHAGES; MONOCYTES; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LDL; RECEPTORS, OXIDIZED LDL; RECEPTORS, SCAVENGER; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS A; SCAVENGER RECEPTORS, CLASS E; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0034014222     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.4.h1042     Document Type: Article

References (31)

1. Armesilla A and Vega MA. Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 269: 18985-18991, 1994.
2. Asch AS, Silbiger S, Heimer E, and Nachman RL. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 182: 1208-1217, 1992.
3. Blann AD, Wang JM, Wilson PB, and Kumar S. Serum levels of the TGF-beta receptor are increased in atherosclerosis. Atherosclerosis 120: 221-226, 1996.
4. Border WA and Noble NA. Targeting TGF-β for treatment of disease. Nat Med 10: 1000-1001, 1995.
5. Bottalico LA, Wager RE, Agellon LB, Assoian RK, and Tabas I. Transforming growth factor-1 inhibits scavenger receptor activity in THP-1 human macrophages. J Biol Chem 266: 22866-22871, 1991.
6. Chen K, Rubock MJ, and Whitman M. A transcriptional partner for MAD proteins in TGF-beta signalling. Nature 383: 691-696, 1996.
7. 2 and activation of protein kinase C. J Biol Chem 269: 27258-27263, 1994.
8. Draude G, Hrboticky N, and Lorenz RL. The expression of the lectin-like oxidized low-density receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its downregulation by lovastatin. Biochem Pharmacol 57: 383-386, 1999.
9. Gong Q and Pitas RE. Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 270: 21672-21678, 1995.
10. Grainger DJ, Witchell CM, and Metcalfe JC. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat Med 1: 1067-1073, 1995.
11. Hrboticky N, Draude G, Hapfelmeier G, Lorenz RL, and Weber PC. Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages. Arterioscler Thromb Vasc Biol 19: 1267-1275, 1999.
12. Imamura T, Takase M, Nishihara A, Oeda E, Hanai JI, Kawabata M, and Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389: 622-626, 1997.
13. Inoue N, Venema R, Sayegh HS, Ohara Y, Murphy TJ, and Harrison DG. Molecular regulation of the bovine endothelial cell nitric oxide synthase by TGF-beta 1. Arterioscler Thromb Vasc Biol 15: 1255-1261, 1995.
14. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueda M, and Morisaki N. In vivo effect of TGF-β1. Enhanced intimai thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler Thromb Vasc Biol 15: 1951-1957, 1995.
15. Kojima S, Harpel PC, and Rifkin DB. Lipoprotein(a) inhibits the generation of transforming growth factor beta: an endogenous inhibitor of smooth muscle cell migration. J Cell Biol 113: 1439-1445, 1991.
16. Kretzschmar M, Doody J, and Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389: 618-621, 1997.
17. Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, and Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83: 322-327, 1998.
18. Lundgren CH, Sawa H, Sobel BE, and Fuji S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 90: 1927-1934, 1994.
19. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, and Reidy MA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest 88: 904-910, 1991.
20. Mietus-Snyder M, Glass CK, and Pitas RE. Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBP-beta. Arterioscler Thromb Vasc Biol 18: 1440-1449, 1998.
21. Nabel EG, Shum L, Pompili ZY, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, and Derynck R. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 90: 10759-10763, 1993.
22. Nakao A, Afrakthe M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, and ten Dijke P. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389: 631-635, 1997.
23. Nishimura N, Harada-Shiba M Tajima S, Sugano R, Yamamura T, Qiang QZ, and Yamamoto A. Acquisition of transforming growth factor-1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line THP-1. J Biol Chem 273: 1562-1567, 1998.
24. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K, Kurata Y, and Matsuzawa Y. Reduced uptake of oxidized low-density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest 96: 1895-1865, 1995.
25. Sawamura T, Kume N, Aoyama T, Moriwaki H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, and Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature 386: 73-77, 1997.
26. Schulick AH, Taylor AJ, Zuo W, Qiu C-B, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, and Dichek DA. Overexpression of transforming growth factor 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 5: 6983-6988, 1998.
27. Schwartz SM, deBlois D, and O'Brian ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
28. Stanton LW, White RT, Bryant CM, Protter AA, and Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem 267: 22446-22451, 1992.
29. Tandon NN, Kralisz U, and Jamieson GA. Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 264: 7576-7583, 1989.
30. Ten Dijke P and Heldin CH. Signal transduction. An anchor for activation. Nature 397: 109-111, 1999.
31. Teupser D, Thiery J, Walli AK, and Seidel D. Determination of LDL-and scavenger-receptor activity in adherent and nonadherent cultured cells with a new single-step fluorimetric assay. Biochim Biophys Acta 1303: 193-198, 1996.